Company overview

HistoSonics is a growth phase company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquefy and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels. The company’s new platform delivers personalized, tissue specific treatments with precision and control, and without the undesirable side effects of many of today’s interventional and surgical modalities. HistoSonics is led by a team of experienced domain experts and industry leaders with offices in Ann Arbor, Michigan and Minneapolis, MN.
Founded in 2009
Minneapolis, Minnesota, USA
307 employees (7 in marketing)

Salaries

Help build salary transparency at HISTOSONICS INC

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

3 open now

Headcount trend

Company growth over the last 12 months

Headcount +45.9% year over year

Funding

Total funding

$328.8M

Last raise

Private Equity, 7 months ago

Funding history

Aug 2025

Private Equity Round HistoSonics

Aug 2024

Series D HistoSonics · $102M

Dec 2022

Debt Financing HistoSonics · $15M

Dec 2022

Convertible Note HistoSonics · $85M

Jun 2020

Series C HistoSonics · $40M

Apr 2019

Series C HistoSonics · $54.7M

Audience

Monthly website visitors
13.2K
Month over month-49.1%
Quarter over quarter+9.8%
Top sourceSearch (49.1%)
Ad budget per month$0.0
Average search rank37.7
Traffic source mix
Search
49.1%
Direct
37.1%
Social
6.3%
Referral
6.1%
Paid referral
1.2%

LinkedIn followers

Follower count and growth

Total followers

26.1K

12-mo growth

+96.1%

Monthly growth

+6.4%

News

Links